TERT and cancer: TERT mRNA expression level has been investigated as a biomarker in addition to telomerase enzymatic activity since it has been shown to be the rate-limiting factor of telomerase activity in a number of cancers, including breast, non-small cell lung, and urothelial cancer (37).